Health Affairs, 24, no. 2 (2005): 536-544 doi: 10.1377/hlthaff.24.2.536 © 2005 by Project HOPE	New Online   How Would Obama, McCain Cover The Uninsured?   Debating Cost Of Uninsured   Try Medicare-For-All   HA Blog Top 10

This Article Figures Only Full Text (HTML) Reprint (PDF) Supplemental Exhibit Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Koyanagi, C. Articles by Alfano, E. Search for Related Content PubMed PubMed Citation Articles by Koyanagi, C. Articles by Alfano, E. Related Collections Access To Care Business Of Health Chronic Care Consumer Issues Health Reform Insurance Coverage Managed Care Medicaid Pharmaceuticals State/Local Issues Health Spending

DataWatch

Medicaid Policies To Contain Psychiatric Drug Costs

This study reviews Medicaid policies to restrict access to psychiatric medications. Policies on prior authorization, preferred drug lists, limitations on the number of prescriptions, fail-first requirements, and use of generics are reviewed. All states apply one or more of those policies to medications for mental illness, and many apply several. A large number of states have legislated exemptions from those policies for certain medications, particularly antipsychotics and antidepressants. Other psychiatric medications are less well protected. Some states appear to restrict access severely. Questions have been raised as to whether these policies actually save money in the long term.

                      What's this?

This article has been cited by other articles:

				S. Ward, A. Pecotich, A. O'Cass, and C. C. Julian A Rose by Any Other Name? The Influence of Brand Name versus Chemical Differences in the Prescription of Antidepressants: The Role of Expertise Journal of Macromarketing, September 1, 2008; 28(3): 258 - 274. [Abstract] [PDF]

				M. R. Law, D. Ross-Degnan, and S. B. Soumerai Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements Psychiatr Serv, May 1, 2008; 59(5): 540 - 546. [Abstract] [Full Text] [PDF]

				S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change Health Aff., May 1, 2008; 27(3): w185 - w195. [Abstract] [Full Text] [PDF]

				J. M. Donohue and R. G. Frank Estimating Medicare Part D's Impact on Medication Access Among Dually Eligible Beneficiaries With Mental Disorders Psychiatr Serv, October 1, 2007; 58(10): 1285 - 1291. [Abstract] [Full Text] [PDF]

				J. J. Guo, P. E. Keck, H. Li, and N. C. Patel Treatment Costs Related to Bipolar Disorder and Comorbid Conditions Among Medicaid Patients With Bipolar Disorder Psychiatr Serv, August 1, 2007; 58(8): 1073 - 1078. [Abstract] [Full Text] [PDF]

				J. C. West, J. E. Wilk, I. L. Muszynski, D. S. Rae, M. Rubio-Stipec, C. L. Alter, W. E. Narrow, and D. A. Regier Medication Access and Continuity: The Experiences of Dual-Eligible Psychiatric Patients During the First 4 Months of the Medicare Prescription Drug Benefit Am J Psychiatry, May 1, 2007; 164(5): 789 - 796. [Abstract] [Full Text] [PDF]

				P. Cunningham, K. McKenzie, and E. F. Taylor The struggle to provide community-based care to low-income people with serious mental illnesses. Health Aff., May 1, 2006; 25(3): 694 - 705. [Abstract] [Full Text] [PDF]

				J. Donohue Mental health in the medicare part d drug benefit: a new regulatory model? Health Aff., May 1, 2006; 25(3): 707 - 719. [Abstract] [Full Text] [PDF]

				N. E. Morden and L. P. Garrison Jr. Implications of part d for mentally ill dual eligibles: a challenge for medicare. Health Aff., March 1, 2006; 25(2): 491 - 500. [Abstract] [Full Text] [PDF]